The Colorectal Cancer Alliance is the leading national patient advocacy organization dedicated to increasing screening rates and survivorship. The Alliance's mission is to knock colon cancer out of the top three cancer killers. It is doing this by championing prevention, funding cutting-edge research and providing the highest quality patient support services and staying true to our values of compassion, respect and commitment.
Colorectal Cancer Alliance Blog
Aug 1, 2017
Bristol-Meyers Squibb’s Opdivo (nivolumab) has just been approved by the FDA for patients with a microsatellite instability-high tumors (also known as MSI-H) or mismatched repair deficiency (dMMR). ... read moreThe post COLORECTAL HEALTH ALERT: Opdivo Approved for MSI-High Colorectal Cancer Patients appeared[…]Read more...
Jul 27, 2017
We can’t thank you enough for your support of the Undy Run/Walk and that’s why we wanted you to be the first to know about ... read moreThe post What the New Undy/Run Walk Fundraising Center Means For You appeared[…]Read more...
Jul 21, 2017
This past June Colon Cancer Alliance staff members attended the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. Each year oncology professionals from ... read moreThe post Top 5 Things to Know about the Latest in Research appeared[…]Read more...
Jun 27, 2017
The revolution has officially begun. With Keytruda, we see a drug that treats different kinds of cancer with the same genetic profile. This is called ... read moreThe post Immunotherapy: The Revolution Has Officially Begun appeared first on Colorectal Cancer[…]Read more...